• Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic.
Ahmad, Gul, et al. J. Infect. Dis. 2011 Nov;204: 1437-49
• Immune senescence in old and very old rhesus monkeys: reduced antibody response to influenza vaccination.
Coe, Christopher L, et al. Age (Dordr) 2012 Oct;34: 1169-77
• Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection.
De Swart, Rik L, et al. J. Virol. 2002 Nov;76: 11561-9
• Juvenile rhesus monkeys have lower type 2 cytokine responses than adults after primary infection with Schistosoma mansoni.
Fallon, Padraic G, et al. J. Infect. Dis. 2003 Mar 15;187: 939-45
• Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.
Fuller, Deborah Heydenburg, et al. J. Virol. 2002 Apr;76: 3309-17
• CpG oligonucleotides induce strong humoral but only weak CD4+ T cell responses to protein antigens in rhesus macaques in vivo.
Hartmann, Gunther, et al. Vaccine 2005 May 09;23: 3310-7
• Age-associated alteration in innate immune response in captive baboons.
McFarlane, Dianne, et al. J. Gerontol. A Biol. Sci. Med. Sci. 2011 Dec;66: 1309-17
• Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques.
Stahl-Hennig, Christiane, et al. PLoS Pathog. 2009 Apr;5: e1000373
• Immunogenicity of DNA vaccines encoding simian immunodeficiency virus antigen targeted to dendritic cells in rhesus macaques.
Tenbusch, Matthias, et al. PLoS ONE 2012;7: e39038
• Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models.
Zhang, Weidong, et al. J. Investig. Med. 2018 Dec;8: 1124-1132